No Data
No Data
3 Reasons Why Growth Investors Shouldn't Overlook Icon PLC (ICLR)
Estimating The Intrinsic Value Of ICON Public Limited Company (NASDAQ:ICLR)
Key Insights ICON's estimated fair value is US$413 based on 2 Stage Free Cash Flow to Equity Current share price of US$336 suggests ICON is potentially trading close to its fair value The US$364
Here's Why Icon PLC (ICLR) Is a Strong Value Stock
Express News | ICON Recognised for Leadership Position in Clinical Research Industry and as Socially Responsible Employer
Drug Middlemen Pay Higher Prices to Their Own Pharmacies, Says FTC
(July 9): Drug middlemen paid their own mail-order pharmacies as much as 200 times more than the price at rival pharmacies for commonly prescribed cancer drugs, allowing them to bring in at least US$1 billion (RM4.71 billion) in excess revenue and potentially raising the costs to patients, the US Federal Trade Commission (FTC) found in an interim study.
Here's How Much You Would Have Made Owning Icon Stock In The Last 15 Years
Icon (NASDAQ:ICLR) has outperformed the market over the past 15 years by 6.54% on an annualized basis producing an average annual return of 19.38%. Currently, Icon has a market capitalization of $26.5